Healthy Upside Potential: Gritstone Bio Inc (GRTS)

With 6.96 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.02 million shares. The 52-week range on GRTS shows that it touched its highest point at $3.33 and its lowest point at $1.14 during that stretch. It currently has a 1-year price target of $9.00. Beta for the stock currently stands at 0.39.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GRTS was down-trending over the past week, with a drop of -14.23%, but this was down by -16.07% over a month. Three-month performance surged to 14.08% while six-month performance rose 50.64%. The stock lost -11.65% in the past year, while it has gained 15.20% so far this year. A look at the trailing 12-month EPS for GRTS yields -1.25 with Next year EPS estimates of -1.00. For the next quarter, that number is -0.33. This implies an EPS growth rate of 12.60% for this year and 4.65% for next year.

Float and Shares Shorts:

At present, 97.59 million GRTS shares are outstanding with a float of 89.41 million shares on hand for trading. On Mar 15, 2024, short shares totaled 8.82 million, which was 8.99% higher than short shares on Feb 15, 2024. In addition to GRTS as the firm’s Gritstone bio, Inc., HRTS serves as its Tema Cardiovascular and Metabol.

Institutional Ownership:

Through their ownership of 43.60% of GRTS’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GRTS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, GRTS has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and GRTS currently yields $0.00. In the past year, GRTS’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, GRTS has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.